EP 2731603 A1 20140521 - STABLE DOSAGE FORMS OF ARTEROLANE AND PIPERAQUINE
Title (en)
STABLE DOSAGE FORMS OF ARTEROLANE AND PIPERAQUINE
Title (de)
STABILE DOSIERUNGSFORMEN VON ARTEROLAN UND PIPERAQUIN
Title (fr)
FORMES POSOLOGIQUES STABLES D'ARTÉROLANE ET DE PIPÉRAQUINE
Publication
Application
Priority
- US 201113183119 A 20110714
- IN 2703DE2011 A 20110919
- IN 2156DE2012 A 20120712
- IB 2012053614 W 20120713
Abstract (en)
[origin: WO2013008218A1] The field of the invention relates to stable oral dosage forms comprising, (a) cis-adamantane-2-spiro-3'-8'-[[[(2'-amino-2'-methylpropyl) amino]carbonyl]-methyl]-l',2',4'-trioxaspiro[4.5]decane hydrogen maleate (Active compound I); (b) piperaquine; and (c) one or more pharmaceutically acceptable excipients; and processes for their preparation, especially wherein the dosage form is prepared by a dry process.
IPC 8 full level
A61K 31/357 (2006.01); A61K 9/20 (2006.01); A61K 31/496 (2006.01); A61P 33/06 (2006.01)
CPC (source: EP)
A61K 9/2054 (2013.01); A61K 9/2077 (2013.01); A61K 9/2095 (2013.01); A61K 31/357 (2013.01); A61K 31/496 (2013.01); A61P 33/06 (2017.12); A61P 43/00 (2017.12); Y02A 50/30 (2017.12)
Citation (search report)
See references of WO 2013008218A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2013008218 A1 20130117; AP 2014007413 A0 20140228; AP 3777 A 20160831; AU 2012282077 A1 20140130; CA 2850089 A1 20130117; CN 103930107 A 20140716; EA 201490233 A1 20140730; EA 201490233 A8 20150130; EP 2731603 A1 20140521; JP 2014522856 A 20140908; KR 20140053169 A 20140507; MX 2014000463 A 20140709
DOCDB simple family (application)
IB 2012053614 W 20120713; AP 2014007413 A 20120713; AU 2012282077 A 20120713; CA 2850089 A 20120713; CN 201280044576 A 20120713; EA 201490233 A 20120713; EP 12743776 A 20120713; JP 2014519689 A 20120713; KR 20147003043 A 20120713; MX 2014000463 A 20120713